Resources

321 Resources for

U.S. Patent and Trademark Office

Subscribe to this listing via:
RSS
Email

Did you mean U.S. Patent and Trademark Office (448 results)

U.S. Patent & Trademark Office Grants Tumbleweed a New Email Signature Patent: REDWOOD CITY, Calif. -- Tumbleweed[R] Communications Corp. (Nasdaq:TMWD), providers of innovative messaging security solutions, today announced that it has been granted U.S. Patent No. 7,127,741 by the U.S. Patent and Trademark Office.; Tags: e-mail; Research articles 2006-11-14
U.S. Patent & Trademark Office Grants Tumbleweed New Message Filtering Patent: REDWOOD CITY, Calif. -- Tumbleweed[R] Communications Corp. (NASDAQ:TMWD), an industry leader in managed file transfer and content security, today announced that it has been granted U.S. Patent No. 7,257,564 by the U.S. Patent and Trademark Office.; Research articles 2007-09-11
U.S. Patent & Trademark Office Grants Tumbleweed a New Email Firewall Patent: REDWOOD CITY, Calif., May 28 /PRNewswire-FirstCall/ -- TumbleweedR Communications Corp. , a leader in managed file transfer and email security, today announced that it has been granted U.S. Patent No. 7,380,274 by the U.S. Patent and Trademark Office.; Tags: e-mail, firewall; Research articles 2008-05-28
U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent: NEW YORK -- Pfizer Inc announced today that the U.S. Patent & Trademark Office has issued a communication notifying the company that it will confirm the patentability of the claims of Pfizer's '893 basic patent for Lipitor. The Patent Office had conducted a re-examination of the '893 patent in response...; Tags: Lipitor, patent, Pfizer Inc., U.S. Patent and Trademark Office; Research articles 2008-04-30
U.S. Patent & Trademark Office Grants Tumbleweed a New Spam Filtering Patent: REDWOOD CITY, Calif. -- Tumbleweed[R] Communications Corp. (Nasdaq:TMWD), a leading provider of email security, managed file transfer, and identity validation appliance and software products, today announced that it has been granted U.S. Patent No. 7,117,358 by the U.S. Patent and Trademark Office.; Tags: spam filtering; Research articles 2006-10-10

U.S. Patent & Trademark Office Grants Tumbleweed a New Digital Certificate Patent: REDWOOD CITY, Calif. -- TumbleweedR Communications Corp. (NASDAQ:TMWD), a leading provider of email security, managed file transfer, and identity validation appliance and software products, today announced that it has been granted U.S. Patent No. 7,073,056 by the U.S. Patent and Trademark Office.; Tags: digital certificate; Research articles 2006-07-05
e-FoodSafety.com, Inc. Files with U.S. Patent and Trademark Office for Additional Patent: PRESCOTT, Ariz. -- e-FoodSafety.com, Inc. (OTC BB: EFSF), a Prescott, Arizona firm that provides effective methods and products to ensure the safety of fruits, vegetables and meats, today announced that a utility patent application had been filed with the U.S. Patent and Trademark Office on August 26, 2004 titled SYSTEM...; Tags: U.S. Patent and Trademark Office; Research articles 2004-09-07
U.S. Patent & Trademark Office Rejects Claims in Synopsys Patent, Magma Announces: SANTA CLARA, Calif. -- The U.S. Patent and Trademark Office today rejected all the claims in Synopsys Inc.'s patent number 6,378,114 (the '114 patent), calling into question the validity of the patent, MagmaR Design Automation Inc. (Nasdaq:LAVA) said in a statement today. The validity of the '114 patent has been...; Tags: patent; Research articles 2006-08-17
U.S. Patent and Trademark Office Grants Artes Medical's Request for Reexamination of Competitor's Patent: SAN DIEGO -- Artes Medical Inc., a privately-held specialty pharmaceutical and medical device company, announced today that the U.S. Patent and Trademark Office USPTO has granted its request for reexamination of the Aventis patent that covers injectable skin fillers using poly-lactic-acid PLA microspheres, marketed in the U.S. under the SculptraTM...; Tags: Aventis, patent, U.S. Patent and Trademark Office; Research articles 2005-01-06
U.S. Patent and Trademark Office changing to electronic format: The U.S. Patent and Trademark Office USPTO is changing to an electronic format for the electronic certified copies it supplies of U.S. patent applications as filed, and U.S. patent-related file wrappers and contents.; Tags: U.S. Patent and Trademark Office; Research articles 2004-08-17
U.S. Patent and Trademark Office Issues Patent to CDEX Inc.; Patent Provides System and Method for Detecting a Chemical Substance Using X-Ray Fluorescence: ROCKVILLE, Md. -- CDEX Inc. (OTCBB:CEXI) announced today that the U.S. Patent and Trademark Office USPTO has issued patent number 7,106,826 to CDEX Inc. The patent is a system and method patent for detecting chemical substances using x-ray fluorescence.; Tags: U.S. Patent and Trademark Office; Research articles 2006-09-14
U.S. Patent and Trademark Office finalizes rejection of central claim in Vitronics vs. Conceptronic patent litigation: PORTSMOUTH, N.H.--BUSINESS WIRE--April 5, 1995--Conceptronic Inc. (NASDAQ: CNCP) announced today that it received notification yesterday from the United States Patent and Trademark Office that claim No. 1 of Vitronics apparatus patent No. 4,833,301 had been rejected after an appeal by Vitronics Corp.; Tags: patent litigation, U.S. Patent and Trademark Office; Research articles 1995-04-05
CD-Rom, online replace paper at U.S. Patent Office: The U.S. Patent and Trademark Office USPTO will discontinue hard copy publication of the Official Gazette of the U.S. Patent and Trademark Office --Patents after September 24, 2002. Replacing the paper version (which cost $70 per issue or $1,465 annually) are both CD-ROM and online versions of the same information.; Tags: CD-ROM, U.S. Patent and Trademark Office; Research articles 2002-08-22
U.S. Patent and Trademark Office Notifies CollaGenex That It Will Confirm Claims of Reexamined Periostat Patent: NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (Nasdaq:CGPI) today announced that the United States Patent and Trademark Office has issued a Notice of Intent to Issue a Reexamination Certificate confirming the patentability of certain amended claims of United States Patent RE 34,656 (the "'656 Patent"), of which CollaGenex is the exclusive...; Tags: U.S. Patent and Trademark Office; Research articles 2005-03-07
GammaCan Files Additional Patent Applications Covering the Treatment of Malignant Melanoma and Colorectal Cancer with the United States Patent and Trademark Office: KIRYAT ONO, Israel & NEW YORK -- GammaCan International Inc.(OTCBB:GCAN), a developer of immunotherapies for cancer and other diseases, today announced that the Company filed two Continuations in Part CIP with the U.S. Patent and Trademark Office.; Tags: patent application, U.S. Patent and Trademark Office; Research articles 2007-01-04
U.S. Patent and Trademark Office Declares Interference Between RhoMed Patent and Diatide Patent Application; Positive Development for Diatide Patent Estate: LONDONDERRY, N.H.--BW HealthWire--Dec. 4, 1998--Diatide, Inc. (Nasdaq:DITI) announced today that the United States Patent and Trademark Office PTO has declared an interference between a patent application filed by Diatide and a patent issued to a second party, RhoMed Incorporated, a wholly-owned subsidiary of Palatin Technologies Inc. (Nasdaq:PLTN). Diatide's application is...; Tags: U.S. Patent and Trademark Office; Research articles 1998-12-04
Pfizer Receives Initial Communication from U.S. Patent and Trademark Office Regarding Lipitor Basic Patent: NEW YORK -- Pfizer Inc announced today that the U.S. Patent & Trademark Office has issued its first communication in the reexamination of the '893 basic patent for Lipitor, initially rejecting the patent's claims. This initial action, which is how the Office raises its issues with the patentee, will now...; Tags: Lipitor, patent, Pfizer Inc., U.S. Patent and Trademark Office; Research articles 2008-01-14
Cypros Pharmaceutical receives notice of allowance from U.S. Patent and Trademark Office for its cardio/neuroprotective agent: CARLSBAD, Calif.--BUSINESS WIRE--Aug. 4, 1995--Cypros Pharmaceutical Corp. (NASDAQ:CYPR) Friday announced it has received a notice of allowance for the issuance of a composition of matter patent from the U.S. Patent and Trademark Office the PTO.; Tags: agent, U.S. Patent and Trademark Office; Research articles 1995-08-04
Collegium Pharmaceutical Inc. receives Notice of Allowance from U.S. Patent and Trademark Office for Novel Anti-Histamine Combination: CUMBERLAND, R.I. -- Collegium Pharmaceutical, Inc. develops patented products for specialty pharmaceutical companies, today announced that it has received notification from the U.S. Patent and Trademark Office PTO allowing the Company's patent application US Patent 20030130263 "Compositions Containing Both Sedative and Non-Sedative Antihistamines." The patent relates to compositions comprising both...; Tags: U.S. Patent and Trademark Office; Research articles 2004-06-17
Angioplasty Stent Patent Filed in 1987 Issued Dec. 13, 2005 by U.S. Patent and Trademark Office: ATLANTA -- W.H. Wall Family Holdings, LLLP announced today the issuance of U.S. patent number 6,974,475. The patent, entitled "Angioplasty stent" was filed with the U.S. Patent and Trademark Office on December 8, 1987 and issued on December 13, 2005. The abstract of the patent is as follows:; Tags: U.S. Patent and Trademark Office; Research articles 2006-02-07